Subscribe to Newsletter

Jean-Paul Clozel

The Power List 2018 – Business Captains

Jean-Paul Clozel

Chief Executive Officer, Idorsia

Jean-Paul founded Actelion in 1997, together with his wife and work colleagues and friends, and has since built Actelion from a start-up to a multi-billion market capitalization company – acquired by Johnson & Johnson for €27.9 billion in 2017. As part of the transaction with J&J, Actelion spun out its drug discovery operations and early-stage clinical development assets into a newly created company, Idorsia, which Jean-Paul now heads up.

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine